COMMONWEALTH EQUITY SERVICES, LLC - CNS PHARMACEUTICALS INC ownership

CNS PHARMACEUTICALS INC's ticker is CNSP and the CUSIP is 18978H102. A total of 21 filers reported holding CNS PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
COMMONWEALTH EQUITY SERVICES, LLC ownership history of CNS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2022$3,000
-40.0%
20,0000.0%0.00%
Q2 2022$5,000
-16.7%
20,0000.0%0.00%
Q1 2022$6,000
-57.1%
20,0000.0%0.00%
Q4 2021$14,000
-51.7%
20,0000.0%0.00%
Q3 2021$29,000
-25.6%
20,0000.0%0.00%
Q2 2021$39,00020,0000.00%
Other shareholders
CNS PHARMACEUTICALS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Altium Capital Management LP 534,148$951,0000.36%
CVI Holdings, LLC 415,652$740,0000.14%
ESSEX INVESTMENT MANAGEMENT CO LLC 61,307$109,0000.01%
Warberg Asset Management LLC 14,000$25,0000.01%
Alpha Cubed Investments, LLC 10,000$18,0000.00%
Integrated Advisors Network LLC 10,700$19,0000.00%
Core Wealth Advisors, Inc. 550$1,0000.00%
OSAIC HOLDINGS, INC. 5,000$9,0000.00%
WELLS FARGO & COMPANY/MN 41$00.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of CNS PHARMACEUTICALS INC shareholders